You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
|
|---|---|
| Published in |
Alzheimer's Research & Therapy, August 2020
|
| DOI | 10.1186/s13195-020-00663-w |
| Pubmed ID | |
| Authors |
Martin Tolar, Susan Abushakra, John A. Hey, Anton Porsteinsson, Marwan Sabbagh |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 22% |
| United Kingdom | 3 | 17% |
| Czechia | 2 | 11% |
| France | 1 | 6% |
| Unknown | 8 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 89% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 435 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 435 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 45 | 10% |
| Student > Master | 43 | 10% |
| Student > Ph. D. Student | 40 | 9% |
| Student > Bachelor | 40 | 9% |
| Other | 28 | 6% |
| Other | 48 | 11% |
| Unknown | 191 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 43 | 10% |
| Biochemistry, Genetics and Molecular Biology | 42 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 37 | 9% |
| Medicine and Dentistry | 37 | 9% |
| Agricultural and Biological Sciences | 20 | 5% |
| Other | 45 | 10% |
| Unknown | 211 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 127. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2024.
All research outputs
#334,299
of 25,743,152 outputs
Outputs from Alzheimer's Research & Therapy
#49
of 1,500 outputs
Outputs of similar age
#10,302
of 426,979 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#1
of 39 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,500 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,979 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.